Landscape of alcohol-related hepatocellular carcinoma in the last 15 years highlights the need to expand surveillance programs
JHEP Reports · 2023-08 · 5 (8) · 100784
DOI: 10.1016/j.jhepr.2023.100784 ↗Kurz gefasst
Fachartikel in der Zeitschrift JHEP Reports, 2023-08. Verfasst von Nicola Reggidori und 31 weiteren Autor:innen. Beteiligte Einrichtung: Unit of Semeiotics, Liver and Alcohol-Related Diseases, IRCCS Azienda Ospedaliero-Universitaria di Bologna, Bologna, Italy. Die Arbeit wurde bisher 12-mal zitiert (Crossref) und nennt 32 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0).
Abstract (Originalsprache)
Background & Aims: Alcohol abuse and metabolic disorders are leading causes of hepatocellular carcinoma (HCC) worldwide. Alcohol-related aetiology is associated with a worse prognosis compared with viral agents, because of the lower percentage of patients diagnosed with HCC under routine surveillance and a higher burden of comorbidity in alcohol abusers. This study aimed to describe the evolving clinical scenario of alcohol-related HCC over 15 years (2006-2020) in Italy.
Methods
Data from the Italian Liver Cancer (ITA.LI.CA) registry were used: 1,391 patients were allocated to three groups based on the year of HCC diagnosis (2006-2010; 2011-2015; 2016-2020). Patient characteristics, HCC treatment, and overall survival were compared among groups. Survival predictors were also investigated.
Results
Approximately 80% of alcohol-related HCCs were classified as cases of metabolic dysfunction-associated fatty liver disease. Throughout the quinquennia,
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Unit of Semeiotics, Liver and Alcohol-Related Diseases, IRCCS Azienda Ospedaliero-Universitaria di Bologna, Bologna, Italy.
- Unit of Semeiotics, Liver and Alcohol-Related Diseases, Department of Medical and Surgical Sciences, Alma Mater Studiorum-University of Bologna, Bologna, Italy.
- Gastroenterology Unit, Belcolle Hospital, Viterbo, Italy.
- Department of Surgery, Oncology, and Gastroenterology, Gastroenterology Unit, University of Padova, Padua, Italy.
- Gastroenterology Unit, Ospedale Sacro Cuore Don Calabria, Negrar, Italy.
- Division of Internal Medicine, Hepatobiliary and Immunoallergic Diseases, IRCCS Azienda Ospedaliero-Universitaria di Bologna, Bologna, Italy.
Zitieren
APA
Reggidori, N., Bucci, L., Santi, V., Stefanini, B., Lani, L., Rampoldi, D., Ghittoni, G., Farinati, F., Masotto, A., Stefanini, B., Mega, A., Biasini, E., Foschi, F. G., Svegliati-Baroni, G., Sangiovanni, A., Campani, C., Raimondo, G., Vidili, G., Gasbarrini, A., …, & Italian Liver Cancer (ITA.LI.CA) group (2023). Landscape of alcohol-related hepatocellular carcinoma in the last 15 years highlights the need to expand surveillance programs. JHEP Reports, 5(8), 100784. https://doi.org/10.1016/j.jhepr.2023.100784
Vancouver
Reggidori N, Bucci L, Santi V, Stefanini B, Lani L, Rampoldi D, et al. Landscape of alcohol-related hepatocellular carcinoma in the last 15 years highlights the need to expand surveillance programs. JHEP Reports. 2023;5(8):100784. doi:10.1016/j.jhepr.2023.100784
BibTeX
@article{Reggidori2023,
author = {Reggidori, Nicola and Bucci, Laura and Santi, Valentina and Stefanini, Benedetta and Lani, Lorenzo and Rampoldi, Davide and Ghittoni, Giorgia and Farinati, Fabio and Masotto, Alberto and Stefanini, Bernardo and Mega, Andrea and Biasini, Elisabetta and Foschi, Francesco Giuseppe and Svegliati-Baroni, Gianluca and Sangiovanni, Angelo and Campani, Claudia and Raimondo, Giovanni and Vidili, Gianpaolo and Gasbarrini, Antonio and Celsa, Ciro and Di Marco, Mariella and Giannini, Edoardo G and Sacco, Rodolfo and Brunetto, Maurizia Rossana and Azzaroli, Francesco and Magalotti, Donatella and Morisco, Filomena and Rapaccini, Gian Ludovico and Nardone, Gerardo and Vitale, Alessandro and Trevisani, Franco and Italian Liver Cancer (ITA.LI.CA) group, Italian Liver Cancer (ITA.LI.CA) group},
title = {Landscape of alcohol-related hepatocellular carcinoma in the last 15 years highlights the need to expand surveillance programs},
journal = {JHEP Reports},
year = {2023},
volume = {5},
number = {8},
pages = {100784},
doi = {10.1016/j.jhepr.2023.100784}
}
EUVIMED